Related references
Note: Only part of the references are listed.Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2013)
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
Dong-Anh Khuong-Quang et al.
ACTA NEUROPATHOLOGICA (2012)
Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology
M. H. A. Jansen et al.
CANCER TREATMENT REVIEWS (2012)
Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma
Andrea Chassot et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas
Stephanie Puget et al.
PLOS ONE (2012)
Nimotuzumab for pediatric diffuse intrinsic pontine gliomas
Maura Massimino et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG
Ute Bartels et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
Birgit Geoerger et al.
NEURO-ONCOLOGY (2011)
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium
Ian F. Pollack et al.
NEURO-ONCOLOGY (2011)
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
J. Russell Geyer et al.
EUROPEAN JOURNAL OF CANCER (2010)
Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma
Alberto Broniscer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets
Maryam Zarghooni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A children's oncology group phase II study
David N. Korones et al.
PEDIATRIC BLOOD & CANCER (2008)
The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms
Hariyadarshi Pannu et al.
JOURNAL OF NEUROSURGERY (2006)
Intraturnoral hemorrhage among children with newly diagnosed, diffuse brainstern glioma
A Broniscer et al.
CANCER (2006)
Diffuse brainstem glioma in children: critical review of clinical trials
D Hargrove et al.
LANCET ONCOLOGY (2006)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Temozolomide in malignant gliomas of childhood: A United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup study
LS Lashford et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Treatment of paediatric pontine glioma with oral trophosphamide and etoposide
JEA Wolff et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
